多期MRI瘤内与瘤周影像组学预测肝细胞癌早期进展的多中心研究
该多中心回顾性研究纳入249例接受根治性切除或TACE的肝细胞癌患者,治疗前均行多期MRI检查。从动脉期、门静脉期及减影delta期提取瘤内与瘤周影像组学特征,构建整合多期相影像组学模型(MP-RM)。结果显示MP-RM在训练集1年AUC为0.819、C指数0.774,外部验证集1年AUC为0.774、C指数0.653,可对HCC早期进展进行风险分层。
要点
- 整合瘤内与瘤周、多期相MRI影像组学特征可提升HCC早期进展预测效能,优于单一期相模型。
- MP-RM可区分高低风险组,训练集HR=3.95(p<0.01),验证集HR=1.56(p=0.05)。
- 该模型在AFP水平、BCLC分期、治疗方式及年龄亚组中表现相对稳定。
核心结论
- 整合瘤内与瘤周多期MRI影像组学模型对HCC术后或TACE后早期进展具有中等至良好的预测效能,可辅助风险分层。
研究设计与样本
- 多中心回顾性研究,纳入5家机构249例接受根治性切除或TACE且治疗前有多期MRI的HCC患者。
- 影像组学特征提取自动脉期、门静脉期及减影delta期的瘤内与瘤周区域。
- 特征选择采用mRMR与LASSO,经Cox回归构建各期相模型及整合多期影像组学模型MP-RM。
- 模型评估采用C指数、时间依赖性ROC、校准曲线及决策曲线分析(DCA)。
- 采用SHAP值及特定影像组学特征可视化以增强模型可解释性。
诊断标准与关键数值
- MP-RM训练集1年AUC为0.819,C指数为0.774;外部验证集1年AUC为0.774,C指数为0.653。
- MP-RM预测效能优于单一期相模型。
- MP-RM风险分层后高危组无进展生存期显著缩短,训练集HR=3.95(p<0.01),验证集HR=1.56(p=0.05)。
- SHAP可视化识别出对预测有贡献的关键瘤内与瘤周影像组学特征。
临床应用与阅片要点
- 治疗前多期MRI的瘤内与瘤周影像组学可辅助HCC患者进行早期进展风险分层。
- 临床解读时可关注多期相联合信息,单纯某一期相特征预测价值有限。
- 该模型为影像信息补充手段,尚未达到可直接指导临床决策的水平。
局限性
- 本研究为回顾性设计,存在选择偏倚可能。
- 作者指出需进一步前瞻性验证后方可考虑临床实施。
- 外部验证集C指数相对较低,模型泛化能力有待更多数据检验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality, with early progression (PD) after treatment posing a critical challenge. Reliable predictive models applicable to different treatment modalities are essential for risk stratification and individualized therapy.
MATERIALS AND METHODS: In this multicenter retrospective study, 249 HCC patients from five institutions underwent curative resection or TACE with pre-treatment multiphase MRI. Radiomic features were extracted from intra- and peri-tumoral regions across arterial, portal venous, and subtraction delta phases. Feature selection was performed using mRMR and LASSO, followed by Cox regression to construct phase-specific and integrated multiphase radiomics model (MP-RM). Model performance was evaluated by C-index, time-dependent ROC, calibration, and decision curve analysis (DCA). SHAP values and visualization of specific radiomics features were applied to enhance interpretability.
RESULTS: MP-RM outperformed single-phase models in both training (1-year AUC 0.819; C-index 0.774) and external validation cohorts (1-year AUC 0.774; C-index 0.653). SHAP visualization identified key intra- and peri-tumoral radiomic features contributing to prediction. Risk stratification using MP-RM effectively separated high- and low-risk groups, with significantly shorter progression-free survival in high-risk patients (training HR = 3.95, p < 0.01; validation HR = 1.56, p = 0.05). Subgroup analyses supported relatively stable model performance across AFP levels, BCLC stages, treatment modalities, and age.
CONCLUSION: A multiphase MRI radiomics model integrating intra- and peri-tumoral features demonstrated moderate-to-good performance for predicting early progression in HCC patients treated with resection or TACE. The model may provide complementary information for risk stratification, although further prospective validation is required before clinical implementation.
引用
- Lan, Yan, Zhang, et al. Integrating multiphase MRI radiomics of tumor and peritumoral regions to predict early progression in Hepatocellular Carcinoma: A multicenter study. Eur J Radiol. 2026. PMID: 42413246. doi:10.1016/j.ejrad.2026.113051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。